Pfizer Inc (MIL:1PFE)
€ 24.625 -0.16 (-0.65%) Market Cap: 138.78 Bil Enterprise Value: 192.52 Bil PE Ratio: 34.89 PB Ratio: 1.59 GF Score: 64/100

Pfizer Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 11, 2021 / 06:15PM GMT
Carter Lewis Gould
Barclays Bank PLC, Research Division - Senior Analyst

Okay. Good afternoon, and welcome to day 3 of the Barclays Global Healthcare Conference. My name is Carter Gould. I am senior biopharma analyst here at Barclays. I'm pleased to welcome Pfizer to the conference. Representing the company is CFO and EVP of Supply Chain, Frank D'Amelio. We're also joined by Chuck Triano, SVP, on the IR Squad. I want to welcome both of you as well say thank you and congratulations to the Pfizer team on all the success in developing and rolling out the vaccine. It's truly been astounding to watch, and it's -- particularly acceleration in the past weeks and months, it's been truly remarkable.

So I believe Chuck is going to make some opening comments and Frank as well, and then we'll get into Q&A. Thank you.

Frank A. D;Amelio
Pfizer Inc. - CFO & Executive VP of Global Supply

' -

Thanks, Carter.

Charles E. Triano
Pfizer Inc. - SVP of IR

Great. Thank you, Carter. Thanks for hosting. Good

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot